- ?? Blog ActionCovid1984.org
- ?? Irish Examiner
- Inverse
- ?? Gript media
- Blake-Lemoine - LaMBDA
- ?? Over Dee Wall
- The Defender News
- ?? BreakingNews.ie
- Dr Vernon Coleman
- Rebel News
- Vaccine Choice Canada NEWS
- SHFT Plan
- The Expose
- ?? Robert Pierzyński PJ
- James Roguskii - Substack
- ?? The Burkean
- Liberty Tactics IM
- stewpeters.com
- Technocracy News
- Interesting Engineering
- ?? Media Hub Ireland
- ?? The Irish Inquiry
- ?? Andy Heasman
- ?? GriptMedia
- ?? WeThePeople.ie
- ?? Action-Covid-1984
- ?? Lets wake up our Capital
- ?? Lets Wake Up Call!!!
- WW Freedom Rallies
- Piers Corbyn
- ?? Tracey OMahony
- ?? The Irish Git
- eIRe is falling
- Peter Madden Channel
- rish Farmers,Food & Family
- Gemma O'Doherty
What's new
What's new
Human medicines European public assessment report (EPAR): Strimvelis, autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence, Date of authorisation: 26/05/2016, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Strimvelis, autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence, Date of authorisation: 26/05/2016, Revision: 13, Status: Authorised
16 October 2026
Combination Products Operational Group: agendas and highlight reports
Combination Products Operational Group: agendas and highlight reports
16 October 2026
Agenda - Combination Products Operational Group (COMBO) - In vitro Diagnostics - 21 October 2026
Agenda - Combination Products Operational Group (COMBO) - In vitro Diagnostics - 21 October 2026
16 October 2026
Minutes of the CHMP meeting 23-26 March 2026
Minutes of the CHMP meeting 23-26 March 2026
16 October 2026
Concept paper on clinical trials in recipients of kidney transplantation
Concept paper on clinical trials in recipients of kidney transplantation
16 October 2026
Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2026, 09:00 (CET) to 20 November 2026, 13:00 (CET)
Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2026, 09:00 (CET) to 20 November 2026, 13:00 (CET)
15 October 2026
Human medicines European public assessment report (EPAR): Optruma, raloxifene, Date of authorisation: 05/08/1998, Revision: 28, Status: Withdrawn
Human medicines European public assessment report (EPAR): Optruma, raloxifene, Date of authorisation: 05/08/1998, Revision: 28, Status: Withdrawn
15 October 2026
Referral: Rifadin oral suspension and syrup and associated names, rifampicin Article 31 referrals Procedure started, 15/10/2026
Referral: Rifadin oral suspension and syrup and associated names, rifampicin Article 31 referrals Procedure started, 15/10/2026
15 October 2026